RET kinase inhibitors for RET-altered thyroid cancers

por Vodopivec, Danica M., Hu, Mimi I.
Publicado 2022

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer

por Cabanillas, Maria E., Hu, Mimi I., Durand, Jean-Bernard, Busaidy, Naifa L.
Publicado 2011

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance

por Hamidi, Sarah, Hofmann, Marie-Claude, Iyer, Priyanka C., Cabanillas, Maria E., Hu, Mimi I., Busaidy, Naifa L., Dadu, Ramona
Publicado 2023

Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment

por Hu, Mimi I., Glezerman, Ilya, Leboulleux, Sophie, Insogna, Karl, Gucalp, Rasim, Misiorowski, Waldemar, Yu, Bennett, Ying, Wendy, Jain, Rajul K.
Publicado 2013

The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision‐making from a fine‐needle aspiration sample

por Krane, Jeffrey F., Cibas, Edmund S., Endo, Mayumi, Marqusee, Ellen, Hu, Mimi I., Nasr, Christian E., Waguespack, Steven G., Wirth, Lori J., Kloos, Richard T.
Publicado 2020

Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid

por Shojaie, Danielle, Hoffman, Aubri S, Amaku, Ruth, Cabanillas, Maria E, Sosa, Julie Ann, Waguespack, Steven G, Zafereo, Mark E, Hu, Mimi I, Grubbs, Elizabeth E
Publicado 2021

Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidism

por Vodopivec, Danica M., Silva, Angelica M., Garcia‐Banigan, Dinamarie C., Christakis, Ioannis, Stewart, Ashley, Schwarz, Kelly, Hussey, Caroline S., Bassett, Roland, Hu, Mimi I., Perrier, Nancy D.
Publicado 2018

MON-LB015 Sporadic MTC in Children: Characterization of a Rare Disease

por Gammons, Sarah, Hu, Mimi I, Zafereo, Mark E, Busaidy, Naifa L, Perrier, Nancy D, Bassett, Roland L, Hyde, Samuel M, Grubbs, Elizabeth G, Waguespack, Steven G
Publicado 2020

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

por Wirth, Lori J, Brose, Marcia S, Elisei, Rossella, Capdevila, Jaume, Hoff, Ana O, Hu, Mimi I, Tahara, Makoto, Robinson, Bruce, Gao, Ming, Xia, Meng, Maeda, Patricia, Sherman, Eric
Publicado 2022

MON-LB88 Positive Predictive Value of TP53 Variants in Bethesda III/IV Thyroid Fine-Needle Aspirates

por Livhits, Masha J, Hu, Mimi I, Waguespack, Steven G, Wirth, Lori J, Ladenson, Paul W, Stack, Brendan C, Hao, Yangyang, Babiarz, Joshua E, Kennedy, Giulia C, Kloos, Richard T
Publicado 2020

Neoadjuvant selpercatinib for advanced medullary thyroid cancer

por Jozaghi, Yelda, Zafereo, Mark, Williams, Michelle D., Gule‐Monroe, Maria K., Wang, Jennifer, Grubbs, Elizabeth G., Vaporciyan, Ara, Hu, Mimi I., Busaidy, Naifa, Dadu, Ramona, Waguespack, Steven G., Subbiah, Vivek, Cabanillas, Maria
Publicado 2020

MON-491 TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center

por Fazeli, Sasan, Dadu, Ramona, Waguespack, Steven G, Sherman, Steven I, Busaidy, Naifa Lamki, Hu, Mimi I, Jimenez, Camilo, Habra, Mouhammed A, Williams, Michelle, Altameemi, Lina, Poropatich, Kate, Routbort, Mark J, Luthra, Raja, Patel, Keyur P, Cabanillas, Maria
Publicado 2020

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns

por Nguyen, Ha, Shah, Komal, Waguespack, Steven G, Hu, Mimi I, Habra, Mouhammed Amir, Cabanillas, Maria E, Busaidy, Naifa L, Bassett, Roland, Zhou, Shouhao, Iyer, Priyanka C, Simmons, Garrett, Kaya, Diana, Pitteloud, Marie, Subudhi, Sumit K, Diab, Adi, Dadu, Ramona
Publicado 2021

Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules

por Hu, Mimi I, Waguespack, Steven G, Dosiou, Chrysoula, Ladenson, Paul W, Livhits, Masha J, Wirth, Lori J, Sadow, Peter M, Krane, Jeffrey F, Stack, Brendan C, Zafereo, Mark E, Ali, Syed Z, Weitzman, Steven P, Hao, Yangyang, Babiarz, Joshua E, Kennedy, Giulia C, Kloos, Richard T
Publicado 2021

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies

por Hegde, Aparna, Andreev-Drakhlin, Alexander Y, Roszik, Jason, Huang, Le, Liu, Shuang, Hess, Kenneth, Cabanillas, Maria, Hu, Mimi I, Busaidy, Naifa L, Sherman, Steven I, Dadu, Ramona, Grubbs, Elizabeth G, Ali, Siraj M, Lee, Jessica, Elamin, Yasir Y, Simon, George R, Blumenschein, Jr, George R, Papadimitrakopoulou, Vassiliki A, Hong, David, Meric-Bernstam, Funda, Heymach, John, Subbiah, Vivek
Publicado 2020